Core Viewpoint - The establishment of the "National Medicine AI Avatar" product by Guoshengtang represents a significant milestone in the application of AI technology within traditional Chinese medicine, potentially reshaping the service model and competitive landscape of the industry [1][2]. Group 1: AI Product Launch and Impact - Guoshengtang has launched its first "National Medicine AI Avatar," which replicates the capabilities of renowned physician Li Hao, allowing for enhanced patient service and significantly increasing the supply of quality medical care [2][3]. - The AI Avatar product is seen as a breakthrough in addressing the challenges faced by the traditional Chinese medicine sector, such as the scarcity of top experts and long training cycles for new practitioners [6][7]. Group 2: Infrastructure and Resource Development - Since its establishment in 2010, Guoshengtang has developed a proprietary IT system, accumulating extensive medical data, including 17 million patient visits and over 8 million cases, which supports the training and optimization of AI models [4]. - The company has built a network of 8 national masters and hundreds of provincial-level renowned physicians, facilitating real-time feedback and continuous improvement of AI capabilities [4][9]. Group 3: Business Model and Growth Strategy - Guoshengtang aims to transition from a medical service provider to an AI medical platform, creating new revenue streams and growth models through the deployment of AI technologies [7][8]. - The AI Avatar allows the company to serve a larger patient base simultaneously, leading to exponential growth in potential customers and a significant expansion of market size [8]. Group 4: Long-term Value and Competitive Advantage - The integration of AI technology not only enhances service efficiency but also reduces marginal costs, potentially increasing profit margins and overall profitability [8]. - By cultivating young doctors through AI training, Guoshengtang is positioned to dominate talent supply in the industry, enhancing its competitive edge and industry influence [9].

Group 1 - A video blogger has reported Shijiazhuang Puzhe Hospital for allegedly including 27.2 mg of diazepam in a traditional Chinese medicine prescription, prompting an investigation by local market supervision authorities [1] - The issue of illegal mixing of Western medicine into traditional Chinese medicine or health products is not new, with various cases reported where banned substances were added to products for weight loss, pain relief, and blood sugar control [1] - Recent actions by the National Health Commission and the State Administration for Market Regulation have targeted the medical beauty, assisted reproduction, and health industries, but many issues resurface after short-term crackdowns [2] Group 2 - To address the problem of illegal mixing of Western medicine, there is a need for a comprehensive regulatory system for the health industry, including the establishment of a department for patient and consumer rights within the National Health Commission [2][3] - The implementation of the Basic Medical and Health Promotion Law provides an opportunity for the National Health Commission to extend its regulatory authority to encompass broader health behaviors across various industries [3] - The health sector has historically focused more on products than services, leading to a reliance on selling health products rather than promoting legitimate health services, which can result in illegal practices when faced with regulatory pressures [4]

| 序号 | 检验项目 | 检测方法 | | --- | --- | --- | | 1 | 地西洋 | BJS 201710 | | | | *** JL 20 A 10 12 11 | 近日，网络博主大斌于5月17日发布的一则视频在网上掀起轩然大波。视频中称，一位刘姓消费者通过互联网问诊，在河北普泽医养服务有限公司石家庄中 医医院（简称"普泽中医院"）购买了治疗失眠的中药饮剂，然而服用后却迅速出现嗜睡反应，消费者怀疑药液存在问题。随后，经两家检测机构检测，该中 药液中被检出含有国家管制的第二类精神药品地西泮（俗称"安定"），剩余药剂已进行公证封存，以配合后续调查。 截图来自网络 据了解，地西泮属于《精神药品管理条例》严格管制的第二类精神药品，长期或过量使用可能导致依赖性和成瘾性。此次检测结果直接指向中药制剂非法添 加西药成分，这不仅严重违反了中医药"纯天然"的原则，更可能对患者的健康造成长期且难以预估的危害。 5月19日，石家庄市桥西区市场监督管理局发布情况通报称，已就此问题对涉事的普泽中医院进行立案调查。目前，该案件正在紧锣密鼓地调查之中，后续 将根据调查结果依法依规进行处置。 事件曝光后，有媒体报道普 ...

云太医郑州分院(素朴中医院)苏慧敏主任是河南省"双心诊疗"领域的开拓者，被誉为"河南双心门诊第一 人"。 她深耕心血管疾病与心理疾病诊疗领域40余年，独创"中西医结合双心诊疗"模式，强调"治心"与"治 身"并重。 医德至善：以患者为中心的温度医疗 "医者行医，当以德为先。"这是苏慧敏教授常挂嘴边的话。面对因反复就医而身心俱疲的患者，她总是 以耐心倾听化解其焦虑，用通俗易懂的科普破除"疾病迷信"。 在当今快节奏的社会中，心血管疾病与心理疾病的交织问题日益凸显。许多患者长期饱受心慌、胸闷、 焦虑、抑郁的折磨，却在反复检查中找不到器质性病变的根源，最终陷入"躯体症状反复，心理负担加 重"的恶性循环。 面对这一难题，云太医郑州分院(素朴中医院)苏慧敏教授以"双心诊疗"为核心，融合中医智慧与现代医 学，为无数患者点亮了希望之光。 医术精诚：破解双心疾病的"身心密码" 云太医平台：打破壁垒的智慧医疗 为让优质医疗资源惠及更多患者，苏慧敏教授携手云太医郑州分院(素朴中医院)，打造"线上+线下"融 合诊疗新模式。 患者通过小程序即可预约视频问诊，无需奔波即可与专家"面对面"交流。 平台还提供中药代煎邮寄、用药指导、愈后跟踪等 ...

Group 1 - The increasing incidence of adenoid hypertrophy in children has garnered significant attention from parents and society, while traditional surgical removal methods face controversy due to associated risks and high postoperative recurrence rates [1] - Cloud Traditional Medicine Zhengzhou Branch (Supu Traditional Chinese Medicine Hospital) collaborates with pediatric expert Professor Meng Niu'an to develop effective Traditional Chinese Medicine (TCM) treatment plans for adenoid hypertrophy, aiming to provide safe and effective holistic treatment for children [2][4] - The platform emphasizes the integration of TCM wisdom and modern medical services, establishing a comprehensive internet medical platform that collaborates with nearly a hundred medical experts across various fields, breaking geographical barriers to enhance healthcare accessibility [2][7] Group 2 - Professor Meng Niu'an identifies the underlying issues of phlegm, heat, and stasis in children with adenoid hypertrophy, suggesting that treatment should focus on strengthening the spleen and stomach, clearing phlegm and heat, and enhancing immunity to alleviate symptoms and improve overall health [4] - Clinical practice demonstrates the effectiveness of individualized treatment approaches, as seen in the case of a 6-year-old boy whose symptoms improved significantly after receiving a tailored TCM regimen from Professor Meng [5] - The cloud-based platform enables the dissemination of personalized treatment plans nationwide, achieving notable therapeutic results for thousands of children suffering from adenoid hypertrophy, thereby contributing to the advancement of TCM pediatrics and the health of children [7]

第三批中国援柬埔寨中医医疗队在柬埔寨开展义诊活动。 第三批中国援柬埔寨中医医疗队队员为柬埔寨当地危重患 者会诊。 中国路桥承建的柬埔寨10号公路改建工程28号大桥。 连接柬埔寨首都金边与西哈努克港的金港高速上的金边收 费站。 航拍的金港高速。 均为受访者提供 扫码观看视频 "够意思"超市、成都火锅、月饼零售，初到柬埔寨首都金边，街头频频出现的中文招牌，会引人探究中 国人在这里的故事。 渊源确实深厚。中国长期是柬埔寨最大贸易伙伴国和最大投资来源国，两国产业链供应链合作不断深 化。柬埔寨第一条高速公路、第一座跨山脊高架桥、第一大电站、最大体育馆……中国支持建设的基础 设施项目，为柬埔寨民众带来实实在在好处，也为柬埔寨长远发展提供有力支撑。 近日，本报记者实地探访部分项目，走近中国援柬埔寨医疗队，感受中国在柬埔寨铺设的"友谊路"和两 国人民的双向奔赴。 "第一高桥"架起来，"有路就有希望" "太开心了，我们从来都没看过这么高的桥是什么样子呢。大家都安排过来看，周围的宾馆、酒店都订 满了。"在柬埔寨"第一高桥"临时通行现场，当地村民乌克占迪喜悦之情溢于言表。 对当地民众来说，大桥和道路带来的是实实在在的发展机会，是更 ...